Literature DB >> 21465699

Mongolia's struggle with liver cancer.

Ted Alcorn.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21465699     DOI： 10.1016/s0140-6736(11)60448-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  A physician order category-based clinical guideline comparison system.

Authors:  Hwan-Jeu Yu; Chia-Ping Shen; Sarangerel Dorjgochoo; Chi-Huang Chen; Jin-Ming Wu; Mei-Shu Lai; Ching-Ting Tan; Chinburen Jigjidsuren; Erdenebaatar Altangerel; Hung-Chang Lee; Chih-Wen Hsueh; Yufang Chung; Feipei Lai
Journal:  J Med Syst       Date:  2012-03-30       Impact factor: 4.460

Review 2.  Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.

Authors:  Katherine A McGlynn; Jessica L Petrick; W Thomas London
Journal:  Clin Liver Dis       Date:  2015-02-26       Impact factor: 6.126

3.  A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.

Authors:  Xiaohua Chen; Odgerel Oidovsambuu; Ping Liu; Rosslyn Grosely; Menashe Elazar; Virginia D Winn; Benjamin Fram; Zhang Boa; Hongjie Dai; Bekhbold Dashtseren; Dahgwahdorj Yagaanbuyant; Zulkhuu Genden; Naranbaatar Dashdorj; Andreas Bungert; Naranjargal Dashdorj; Jeffrey S Glenn
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

4.  Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey.

Authors:  Davaalkham Dambadarjaa; Yerkyebulan Mukhtar; Enkh-Oyun Tsogzolbaatar; Ser-Od Khuyag; Angarmurun Dayan; Nandin-Erdene Oyunbileg; Oyu-Erdene Shagdarsuren; Gunchmaa Nyam; Yosikazu Nakamura; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Prev Med Public Health       Date:  2022-05-20

5.  Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.

Authors:  Marina G Tarakanovskaya; Jigjidsuren Chinburen; Purev Batchuluun; Chogsom Munkhzaya; Genden Purevsuren; Dorjiin Dandii; Tsogkhuu Hulan; Dandii Oyungerel; Galyna A Kutsyna; Alan A Reid; Vika Borisova; Allen I Bain; Vichai Jirathitikal; Aldar S Bourinbaiar
Journal:  J Hepatocell Carcinoma       Date:  2017-04-12

Review 6.  Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan-Korea Oncology Consortium.

Authors:  Chai Hong Rim; Won Jae Lee; Bekhzood Musaev; Ten Yakov Volichevich; Ziyayev Yakhyo Pazlitdinovich; Tillysshaykhov Mirzagaleb Nigmatovich; Jae Suk Rim
Journal:  Int J Environ Res Public Health       Date:  2022-09-17       Impact factor: 4.614

7.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.

Authors:  Ali A Mokdad; Alan D Lopez; Saied Shahraz; Rafael Lozano; Ali H Mokdad; Jeff Stanaway; Christopher J L Murray; Mohsen Naghavi
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

8.  The genomic landscape of Mongolian hepatocellular carcinoma.

Authors:  Julián Candia; Enkhjargal Bayarsaikhan; Mayank Tandon; Anuradha Budhu; Marshonna Forgues; Lkhagva-Ochir Tovuu; Undarmaa Tudev; Justin Lack; Ann Chao; Jigjidsuren Chinburen; Xin Wei Wang
Journal:  Nat Commun       Date:  2020-09-01       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.